Determining the Optimal Examined Lymph Node for Accurate Staging and Long-term Survival in Rectal Cancer

Completed

• Conditions: Rectal Cancer

• Registration Number: NCT05572151
• Lead Sponsor: The Second Affiliated Hospital of Harbin Medical University

Brief Summary

A multi-institutional registry of collected data on patients with rectal cancer who underwent surgical resection between January 2009 and December 2018 at the departments of colorectal surgery of five medical institutions in China

Detailed Description

A multi-institutional registry of collected data on patients with rectal cancer who underwent surgical resection between January 2009 and December 2018 at the departments of colorectal surgery of five medical institutions in China (National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College; Changhai Hospital, Naval Medical University; The Second Affiliated Hospital of Harbin Medical University; The Affiliated Tumor Hospital of Harbin Medical University; The Affiliated Tumor Hospital of Guangxi Medical University)

Study Timeline

• Study Start: 2009-01-01
• Primary Completion: 2018-12-10
• Study Completion: 2018-12-31
• Status Verified: 2022-10
• Study First Submitted: 2022-10-04
• Study First Submitted QC: 2022-10-06
• Last Update Submitted: 2022-10-06
• Study First Posted: 2022-10-07
• Last Update Posted: 2022-10-07

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 7694

Inclusion Criteria

• Rectal cancer patients in stage I-III who underwent surgical resection for first primary rectal cancer with at least one lymph node were eligible

Exclusion Criteria

• Patients with missing values on lymph node count and clinical features were excluded

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
lymph node number	during the surgery	lymph nodes were harvested during surgical resection of rectal cancer